Treatment of N,N,N′,N′,N″-Pentamethyl-1,3,5-triazin-2,4,6-triamin with butyllithium and trideuteroiodomethane give N,N,N′,N′,N″-Pentamethyl-N″-(trideuteromethyl)-1,3,5-triazin-2,4,6-triamin, a deuterated analogue of the anticancer drug hexamethylmelamine, in high yield.